MedPharm Research, a leading cannabis researcher, announced today that the company’s proposal, which was submitted to the FY23 Cannabis Research Opportunity at the Colorado State University Institute of Cannabis Research (ICR), titled “Isolation and Pharmacological Evaluation of Phytocannabinoids for Alzheimer’s Disease,” has been selected for funding.
© 420 Intel
Copyright 2019 - 2024. MjInvest.com and MjMicro Cap are divisions of MjLink.com, Inc.. All rights reserved. MjInvest
Legal Disclaimer - https://www.mjinvest.com/legal-disclaimer
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law:
You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
